Trailing-twelve-month (TTM) net income is $4.87 Billion with a year-over-year change of (6.41%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q3 FY2026 (2026-08-02): $1.38B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$4.87B
$4.87 Billion
(6.41%)
vs. $5.21B a year ago (TTM)
(2.17%)
5 Year compound annual growth rate
1 Year
(6.41%)
3 Year
(21.36%)
5 Year
(2.17%)
10 Year
+11.85%
15 Year
+4.31%
20 Year
+5.56%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.03B | ($2.07B) | (29.20%) |
| 2024 | $7.10B | ($3.07B) | (30.16%) |
| 2023 | $10.17B | +$3.04B | +42.56% |
| 2022 | $7.13B | +$1.17B | +19.59% |
| 2021 | $5.96B | +$3.21B | +116.76% |
| 2020 |
TTM Growth
(6.41%)
3-Year CAGR
(21.36%)
5-Year CAGR
(2.17%)
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-09T20:00:02.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
| $2.75B |
| ($502.00M) |
| (15.43%) |
| 2019 | $3.25B | +$885.00M | +37.37% |
| 2018 | $2.37B | +$209.00M | +9.68% |
| 2017 | $2.16B | +$635.10M | +41.68% |
| 2016 | $1.52B | ($416.10M) | (21.45%) |
